Tech
FDA orders class-wide GLP-1 label update to include risk for rare eye disease
Article URL: https://www.biospace.com/fda/fda-orders-class-wide-glp-1-label-update-to-include-potential-risk-for-rare-eye-disease Comments URL…
The Food and Drug Administration is adding a new warning about possible rare cases of vision loss reported with GLP-1 drugs like Ozempic, Wegovy and other brands.
Discussion (0)
No comments yet. Start the conversation!